Air force/texas coronary atherosclerosis prevention study (afcaps/texcaps): Additional perspectives on tolerability of long-term treatment with lovastatin

This publication has 16 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Antiatherothrombotic Properties of Statins
  JAMA, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor
  Archives of internal medicine (1960), 1998
• Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
  The American Journal of Cardiology, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
  Clinical Pharmacology & Therapeutics, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Lovastatin and coadministered antihypertensive/cardiovascular agents.
  Hypertension, 1992
• Expanded Clinical Evaluation of Lovastatin (EXCEL) Study Results
  Archives of internal medicine (1960), 1991